Xilio Therapeutics (XLO) Insider Trading & Ownership → Tiny AI projects with huge promise hiding in plain sight … (From Weiss Ratings) (Ad) Free XLO Stock Alerts $1.07 -0.05 (-4.46%) (As of 08:43 AM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Xilio Therapeutics (NASDAQ:XLO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.60%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$368,790.00Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$1,831.54 Get XLO Insider Trade Alerts Want to know when executives and insiders are buying or selling Xilio Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address XLO Insider Buying and Selling by Quarter Ad Manward PressThe most important AI company you've never heard ofBecause this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products.Get the full story on this secret AI company poised for massive growth Xilio Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/2/2024Gilead Sciences, Inc.Major ShareholderBuy485,250$0.76$368,790.00 2/8/2024Venture Fund Xi L.P. AtlasMajor ShareholderSell733$0.64$469.12 1/11/2024Venture Fund Xi L.P. AtlasMajor ShareholderSell1,566$0.87$1,362.42 (Data available from 1/1/2013 forward) XLO Insider Trading Activity - Frequently Asked Questions Who is on Xilio Therapeutics's Insider Roster? The list of insiders at Xilio Therapeutics includes Bain Capital Life Sciences Inv, Gilead Sciences, Inc., Rock Springs Capital Managemen, and Venture Fund Xi L.P. Atlas. Learn more on insiders at XLO. What percentage of Xilio Therapeutics stock is owned by insiders? 4.60% of Xilio Therapeutics stock is owned by insiders. Learn more on XLO's insider holdings. Which Xilio Therapeutics insiders have been buying company stock? The following insider purchased XLO shares in the last 24 months: Gilead Sciences, Inc. ($368,790.00). How much insider buying is happening at Xilio Therapeutics? Insiders have purchased a total of 485,250 XLO shares in the last 24 months for a total of $368,790.00 bought. Which Xilio Therapeutics insiders have been selling company stock? The following insider sold XLO shares in the last 24 months: Venture Fund Xi L.P. Atlas ($1,831.54). How much insider selling is happening at Xilio Therapeutics? Insiders have sold a total of 2,299 Xilio Therapeutics shares in the last 24 months for a total of $1,831.54 sold. More Insider Trading Tools from MarketBeat Related Companies: Immuneering Insider Ownership Nabriva Therapeutics Insider Ownership Sensei Biotherapeutics Insider Ownership HCW Biologics Insider Ownership Lexaria Bioscience Insider Ownership Unicycive Therapeutics Insider Ownership Ocuphire Pharma Insider Ownership Cara Therapeutics Insider Ownership Clene Insider Ownership Eyenovia Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:XLO) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsDoes this make you sick?Allegiance Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xilio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.